Kyverna Therapeutics Inc. will make its trading debut on the Nasdaq Global Market, under the ticker symbol, "KYTX" today, Feb.8, 2024.This clinical-stage biopharmaceutical company is developing cell therapies for patients suffering from autoimmune diseases.About 14.5 million shares will be sold in the IPO at a price of $22 per share.The offering, which is scheduled to close on or about February 1...
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.